Literature DB >> 17633058

Peritonectomy procedures.

P H Sugarbaker1.   

Abstract

Mesh：

Year:  2007        PMID： 17633058     DOI： 10.1007/978-0-387-48993-3_15

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  16 in total

1.  Extraperitoneal Approach During Peritonectomy in the Right Upper Quadrant for Peritoneal Metastases from Ovarian Malignancies.

Authors:  Miklos Acs; Hubert Leebmann; Sebastian Häusler; Philipp Harter; Pompiliu Piso
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

Review 2.  Primary and metastatic peritoneal surface malignancies.

Authors:  Delia Cortés-Guiral; Martin Hübner; Mohammad Alyami; Aditi Bhatt; Wim Ceelen; Olivier Glehen; Florian Lordick; Robert Ramsay; Olivia Sgarbura; Kurt Van Der Speeten; Kiran K Turaga; Manish Chand
Journal:  Nat Rev Dis Primers       Date:  2021-12-16       Impact factor: 52.329

3.  Second-look Surgery for Appendiceal High Grade and Colorectal Cancers Following Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Authors:  Mohammad Breakeit; Daniel Liu; Adrian Cheng; Hyerim Suh; Shoma Barat; Amer Matar; Nayef Alzahrani; David L Morris
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

Review 4.  Extravascular use of drug-eluting beads: a promising approach in compartment-based tumor therapy.

Authors:  Simon Binder; Andrew L Lewis; J-Matthias Löhr; Michael Keese
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

5.  Experience after 100 patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Ingmar Königsrainer; Derek Zieker; Jörg Glatzle; Olivia Lauk; Julia Klimek; Stephan Symons; Björn Brücher; Stefan Beckert; Alfred Königsrainer
Journal:  World J Gastroenterol       Date:  2012-05-07       Impact factor: 5.742

6.  Does hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patients.

Authors:  Rene Warschkow; Ignazio Tarantino; Jochen Lange; Sascha A Müller; Bruno M Schmied; Michael Zünd; Thomas Steffen
Journal:  Patient Saf Surg       Date:  2012-06-15

7.  Risk factors for postoperative delayed gastric emptying in ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Guang-Xia Cui; Zi-Jun Wang; Jin Zhao; Ping Gong; Shuai-Hong Zhao; Xiao-Xue Wang; Wen-Pei Bai; Yan Li
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

8.  The survival outcome and complication of secondary cytoreductive surgery plus chemotherapy in recurrent ovarian cancer: a systematic review and meta-analysis.

Authors:  Ting Ding; Dan Tang; Mingrong Xi
Journal:  J Ovarian Res       Date:  2021-07-13       Impact factor: 4.234

9.  Diagnosis and management of peritoneal metastases from ovarian cancer.

Authors:  Evgenia Halkia; John Spiliotis; Paul Sugarbaker
Journal:  Gastroenterol Res Pract       Date:  2012-07-19       Impact factor: 2.260

10.  Cytoreductive surgery and HIPEC for peritoneal carcinomatosis in the elderly.

Authors:  J D Spiliotis; E Halkia; V A Boumis; D T Vassiliadou; A Pagoulatou; E Efstathiou
Journal:  Int J Surg Oncol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.